163 related articles for article (PubMed ID: 31729110)
1. SMARCB1 (INI-1) and NUT immunoexpression in a large series of head and neck carcinomas in a Brazilian reference center.
Neves-Silva R; Almeida LY; Silveira HA; Colturato CBN; Duarte A; Ferrisse TM; Silva EV; Vanzolin BF; Bufalino A; Ribeiro-Silva A; León JE
Head Neck; 2020 Mar; 42(3):374-384. PubMed ID: 31729110
[TBL] [Abstract][Full Text] [Related]
2. SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity.
Agaimy A; Hartmann A; Antonescu CR; Chiosea SI; El-Mofty SK; Geddert H; Iro H; Lewis JS; Märkl B; Mills SE; Riener MO; Robertson T; Sandison A; Semrau S; Simpson RH; Stelow E; Westra WH; Bishop JA
Am J Surg Pathol; 2017 Apr; 41(4):458-471. PubMed ID: 28291122
[TBL] [Abstract][Full Text] [Related]
3. SMARCB1 (INI-1)-deficient carcinomas of the sinonasal tract.
Bishop JA; Antonescu CR; Westra WH
Am J Surg Pathol; 2014 Sep; 38(9):1282-9. PubMed ID: 25007146
[TBL] [Abstract][Full Text] [Related]
4. INI-1 (SMARCB1)-Deficient Undifferentiated Sinonasal Carcinoma: Novel Paradigm of Molecular Testing in the Diagnosis and Management of Sinonasal Malignancies.
Shaverdashvili K; Azimi-Nekoo E; Cohen P; Akbar N; Ow TJ; Halmos B; Castellucci E
Oncologist; 2020 Sep; 25(9):738-744. PubMed ID: 32337786
[TBL] [Abstract][Full Text] [Related]
5. SMARCB1-deficient carcinomas of the head and neck region: a cytopathologic characterization.
Kezlarian BE; Lin O; Dogan S
J Am Soc Cytopathol; 2020; 9(6):494-501. PubMed ID: 32839151
[TBL] [Abstract][Full Text] [Related]
6. Metastatic SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma Diagnosed by Endobronchial Ultrasound-Guided Fine-Needle Aspiration (EBUS-FNA): A Potential Diagnostic Pitfall and Review of the Literature.
McHugh KE; Policarpio-Nicolas MLC
Acta Cytol; 2019; 63(5):431-437. PubMed ID: 31132763
[TBL] [Abstract][Full Text] [Related]
7. SMARCB1 (INI-1) - Deficient sinonasal carcinoma: Report of two cases.
Vasudevan G; Srinivas SP; Nayal B; Jayaprakash P; Ramaswamy B
Indian J Pathol Microbiol; 2023; 66(2):352-355. PubMed ID: 37077082
[TBL] [Abstract][Full Text] [Related]
8. Cytopathologic features of SMARCB1 (INI-1)-deficient sinonasal carcinoma.
Allard FD; Bell D; Stelow EB
Cancer Cytopathol; 2018 Aug; 126(8):567-574. PubMed ID: 29797680
[TBL] [Abstract][Full Text] [Related]
9. SMARCB1/INI1-deficient sinonasal carcinoma shows methylation of RASSF1 gene: A clinicopathological, immunohistochemical and molecular genetic study of a recently described entity.
Laco J; Chmelařová M; Vošmiková H; Sieglová K; Bubancová I; Dundr P; Němejcová K; Michálek J; Čelakovský P; Mottl R; Sirák I; Vošmik M; Ryška A
Pathol Res Pract; 2017 Feb; 213(2):133-142. PubMed ID: 28069272
[TBL] [Abstract][Full Text] [Related]
10. Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022: SWI/SNF-deficient Sinonasal Neoplasms: An Overview.
Agaimy A
Head Neck Pathol; 2022 Mar; 16(1):168-178. PubMed ID: 35307773
[TBL] [Abstract][Full Text] [Related]
11. Cytopathologic characteristics of SMARCB1 (INI-1) deficient sinonasal carcinoma: A potential diagnostic pitfall.
Allison DB; Bishop JA; Ali SZ
Diagn Cytopathol; 2016 Aug; 44(8):700-3. PubMed ID: 27177850
[TBL] [Abstract][Full Text] [Related]
12. Poorly differentiated sinonasal tract malignancies: A review focusing on recently described entities.
Agaimy A
Cesk Patol; 2016; 52(3):146-53. PubMed ID: 27526015
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathological characteristics of SMARCB1(INI1)-deficient sinonasal carcinoma].
Wang JY; Bai YP; Xing L; Piao YS; He XJ; Yue CL; Zhao XL; Liu HG
Zhonghua Bing Li Xue Za Zhi; 2021 Nov; 50(11):1240-1245. PubMed ID: 34719161
[No Abstract] [Full Text] [Related]
14. SMARCB1 (INI-1)-Deficient Adenocarcinoma of the Sinonasal Tract: A Potentially Under-Recognized form of Sinonasal Adenocarcinoma with Occasional Yolk Sac Tumor-Like Features.
Shah AA; Jain D; Ababneh E; Agaimy A; Hoschar AP; Griffith CC; Magliocca KR; Wenig BM; Rooper LM; Bishop JA
Head Neck Pathol; 2020 Jun; 14(2):465-472. PubMed ID: 31468350
[TBL] [Abstract][Full Text] [Related]
15. SMARCB1 deficient sinonasal carcinoma: An emerging entity with a diagnostic challenge.
Anila KR; Ginju V; Vishnu VL; Kumar R; Jayasree K
Indian J Pathol Microbiol; 2023; 66(1):159-161. PubMed ID: 36656230
[TBL] [Abstract][Full Text] [Related]
16. [Utility of NUT gene expression and rearrangement in diagnosis of NUT midline carcinoma in upper respiratory tract].
Fang W; French CA; Cameron MJ; Han YD; Liu HG
Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):519-24. PubMed ID: 23157742
[TBL] [Abstract][Full Text] [Related]
17. The first case of SMARCB1 (INI1) - deficient squamous cell carcinoma of the pleura: a case report.
Yoshida K; Fujiwara Y; Goto Y; Kohno T; Yoshida A; Tsuta K; Ohe Y
BMC Cancer; 2018 Apr; 18(1):398. PubMed ID: 29625594
[TBL] [Abstract][Full Text] [Related]
18. Vulvar Yolk Sac Tumors Are Somatically Derived SMARCB1 (INI-1)-Deficient Neoplasms.
Kolin DL; Konstantinopoulos PA; Campos SM; Toumi G; Kolahi KA; Gars EJ; Howitt BE
Am J Surg Pathol; 2022 Feb; 46(2):169-178. PubMed ID: 34265804
[TBL] [Abstract][Full Text] [Related]
19. Sinonasal undifferentiated carcinoma: clinicopathological spectrums and diagnosis reappraisal.
Vaziri Fard E; Zhang S; Cai Z; Ding J; Sun Q; Saluja K; Zhu H
Hum Pathol; 2019 Jul; 89():62-70. PubMed ID: 31054892
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of the diagnosis and treatment of patients with SMARCB1 (INI-1)-deficient sinonasal carcinoma].
Wang LW; Wang R; Fang JG; Zhong LZ; Hou HZ; Ma L; Feng SZ; He CS; Wang L; Zhang L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Jul; 57(7):848-853. PubMed ID: 35866278
[No Abstract] [Full Text] [Related]
[Next] [New Search]